TRANSMED7.COM: Keyword Density Checker

Total words: 2398 | 2-word phrases: 617 | 3-word phrases: 687 | 4-word phrases: 729

PAGE INFO

Title	Try to keep the title under 60 characters (59 characters) TransMed7, LLC – A World Of Challenges. One Solution.
Description	Try to keep the meta description between 50 - 160 characters (202 characters) TransMed7’s transformational forward-coring, Zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow and more.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	llc announces first	12	1.75%
2	transmed7 llc announces	12	1.75%
3	clinical use of	9	1.31%
4	announces first clinical	8	1.16%
5	first clinical use	7	1.02%
6	transmed7 llc announced	6	0.87%
7	multiple collection simc	6	0.87%
8	for commercial launch	6	0.87%
9	devices for commercial	6	0.87%
10	biopsy devices for	6	0.87%
11	– transmed7 llc	6	0.87%
12	insertionmultiple collection simc	5	0.73%
13	single insertionmultiple collection	5	0.73%
14	portola valley ca	5	0.73%
15	vacuumassisted single insertionmultiple	4	0.58%
16	llc announced today	4	0.58%
17	use of vacupac®	3	0.44%
18	of vacupac® a	3	0.44%
19	first clinical cases	3	0.44%
20	clinical cases of	3	0.44%
21	of zero5 technology	3	0.44%
22	zero5 technology to	3	0.44%
23	application of zero5	3	0.44%
24	2023 – transmed7	3	0.44%
25	biopsy for the	2	0.29%
26	concorde family of	2	0.29%
27	september 6 2023	2	0.29%
28	from concorde family	2	0.29%
29	cases of concorde	2	0.29%
30	of concorde soft	2	0.29%

#	Keyword	Frequency	Density
1	transmed7 llc announces first	12	1.65%
2	llc announces first clinical	8	1.10%
3	first clinical use of	7	0.96%
4	devices for commercial launch	6	0.82%
5	– transmed7 llc announced	6	0.82%
6	biopsy devices for commercial	6	0.82%
7	announces first clinical use	6	0.82%
8	single insertionmultiple collection simc	5	0.69%
9	vacuumassisted single insertionmultiple collection	4	0.55%
10	transmed7 llc announced today	4	0.55%
11	of zero5 technology to	3	0.41%
12	first clinical cases of	3	0.41%
13	use of vacupac® a	3	0.41%
14	clinical use of vacupac®	3	0.41%
15	application of zero5 technology	3	0.41%
16	2023 – transmed7 llc	3	0.41%
17	revenue from concorde family	2	0.27%
18	platform of breast biopsy	2	0.27%
19	that the “first in	2	0.27%
20	from concorde family of	2	0.27%
21	of breast biopsy devices	2	0.27%
22	vacuumassist attachment for all	2	0.27%
23	attachment for all of	2	0.27%
24	for all of its	2	0.27%
25	announces first clinical cases	2	0.27%
26	first results from clinical	2	0.27%
27	single insertionmultiple collection simc™	2	0.27%
28	platforms of biopsy devices	2	0.27%
29	clinical use of its	2	0.27%
30	from clinical use of	2	0.27%
31	first revenue from concorde	2	0.27%
32	single insertionmultiple collection simc®	2	0.27%
33	of concorde soft tissue	2	0.27%
34	llc announces first results	2	0.27%
35	announces first results from	2	0.27%
36	cases of concorde soft	2	0.27%
37	clinical cases of concorde	2	0.27%
38	the “first in human”	2	0.27%
39	the field of breast	2	0.27%
40	announces first revenue from	2	0.27%